β2-Glycoprotein I: evolution, structure and function
Humoral immune response to ADAMTS13 in acquired thrombotic thrombocytopenic purpura
Thrombin-inhibiting perfluorocarbon nanoparticles provide a novel strategy for the treatment and magnetic resonance imaging of acute thrombosis
Impact of vascular disease in predicting stroke and death in patients with atrial fibrillation: the Danish Diet, Cancer and Health cohort study
Activated protein C protects against myocardial ischemic/reperfusion injury through AMP-activated protein kinase signaling
Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery
Non-steroidal anti-inflammatory drug use and risk of venous thromboembolism
Coffee consumption and the risk of venous thromboembolism: the Tromsφ study
The AVAIL ME Extension: a multinational Middle Eastern survey of venous thromboembolism risk and prophylaxis
Migraineurs show a high prevalence of antiphospholipid antibodies
Emerging roles for factor XII in vivo
Factor XII activation is essential to sustain the procoagulant effects of particulate matter
Safety and pharmacokinetics of a glycoPEGylated recombinant activated factor VII derivative: a randomized first human dose trial in healthy subjects
S35972, a direct-acting thrombin inhibitor with high oral bioavailability and antithrombotic efficacy
Genome scan of clot lysis time and its association with thrombosis in a protein C-deficient kindred
Vascular endothelial growth factor confers endothelial resistance to apoptosis through poly(ADP-ribose) polymerase
Diagnosis and classification of factor XIII deficiencies
Comparative study of commercially available procarboxypeptidase U (thrombin-activatable fibrinolysis inhibitor) assays
Epigenetic, polymorphic and mutational (Αα167Arg→Lys) contribution to a functionally abnormal fibrinogen
The management of a sub-segmental pulmonary embolism: a cross-sectional survey of Canadian thrombosis physicians
Relationship between thrombospondin gene variations, von Willebrand factor levels and the risk of coronary heart disease in an older population
Increased platelet turnover in patients with previous definite stent thrombosis
Generic versions of enoxaparin available for clinical use in Brazil are similar to the original drug
Genetic and antibody-induced glycoprotein VI deficiency equally protects mice from mechanically and FeCl3-induced thrombosis
von Willebrand factor-to-ADAMTS13 ratio increases with age in a Japanese population
Single-center experience with rituximab as first-line immunosuppression for acquired hemophilia
Acute respiratory tract infection leads to procoagulant changes in human subjects
False-negative or false-positive: laboratory diagnosis of lupus anticoagulant at the time of commencement of anticoagulant: a rebuttal
False negative or false positive: laboratory diagnosis of lupus anticoagulant at the time of commencement of anticoagulant: reply to a rebuttal
A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score: a rebuttal
Join ISTH